Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Conditions: Gorlin Syndrome Interventions: Drug: Patidegib Topical Gel; Drug: Vehicle Gel Sponsors: Sol-Gel Technologies, Ltd.; Premier Research Group plc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials